ThumbPrint: Patient-Anchored Evidence

It's time to stop settling for tokenization. ThumbPrint establishes a direct, consented relationship with participants during the active trial, preserving the full trial cohort and full optionality for future evidence generation, with no matching uncertainty, no cohort loss, and no third-party data dependencies.

Secure the optionality to meet future evidence needs

After a clinical trial closes, your research teams may need a reliable path back to their cohort if evidence needs arise.

01

Long-term real-world safety and effectiveness

02

Trial-anchored treatment outcomes and disease progression

03

HEOR and payer evidence for market access

04

Post-marketing requirements and commitments

05

Evolving regulatory questions that arise years after a trial closes

06

Patient experience and quality of life

MEET YOUR RESEARCH NEEDS

Designed for proactive research teams

98%

Patient Retention

year-over-year in follow-up studies

0%

Trial cohort loss

from identifier or database coverage gaps

UNLOCK RICHER EVIDENCE

What makes our approach different?

Diagram showing a sequence of steps involving a person, documents, brain scan, and code snippets connected by lines with a complex looping pattern underneath.

Full cohort preservation

Unlike tokenization-based approaches, ThumbPrint preserves the relationship with the actual trial participant — maintaining the ability to recontact patients as new data needs arise. Starting from the patient rather than the token, ThumbPrint delivers complete, longitudinal, trial-anchored evidence with the scientific rigor, endpoint fidelity, and future flexibility that connectivity alone cannot provide.

Complementary to tokenization

ThumbPrint fills the specific gap where tokenization underdelivers — when complete trial-anchored journeys, endpoint-level fidelity, long-term follow-up, and patient recontact or re-engagement are required. Tokenization remains valuable for broad HCRU analyses at scale, and new tokens can always be generated from this cohort when needed.

Diagram showing a sequence of steps involving a person, documents, brain scan, and code snippets connected by lines with a complex looping pattern underneath.

Ready when you are

When evidence needs arise, PicnicResearch co-designs a protocol and data model around predefined endpoints, captures complete retrospective and prospective records across all sites of care, and delivers analysis-ready, curated outputs aligned to regulatory and payer requirements.

Learn more

Learn more about ThumbPrint

PicnicHealth Launches ThumbPrint: A Patient-Anchored Alternative to Tokenization
ThumbPrint gives clinical trial sponsors patient-anchored RWE that preserves cohort optionality beyond tokenization
ThumbPrint: Patient-Anchored Evidence
Tokenization leaves gaps. ThumbPrint preserves your full trial cohort for long-term follow-up, post-marketing commitments, and HEOR evidence — with 0% cohort loss and 98% patient retention.
Tokenization Is Not Enough - The Case for Patient-Anchored Trial Evidence
Tokenization has limits. Learn why patient-anchored evidence delivers better long-term follow-up, endpoint fidelity, and regulatory confidence.
Revolutionizing Long-term Follow-up: Modern Technology for Better Results
Long-term follow-up (LTFU) studies are often a complicated and costly requirement for life sciences companies, but they can be greatly simplified with the advent of AI and other new technologies.
Contact Us

Get in touch with our team.

Fill out the form, and one of our experts will contact you for an introductory call.